Description
This guidance aims to articulate Health Canada's expectations and generate a level of consistency regarding the interpretation of the Priority Review of Drug Submissions policy and the filing of a Priority Review request. Additional clarification of the process by which the Priority Review request is assessed is provided.
Resources
| Name | Format | Description | Link |
|---|---|---|---|
| Guidance for Industry - Priority Review of Drug Submissions | HTML | Open resource | |
| Guidance for Industry - Priority Review of Drug Submissions | HTML | Open resource |